A polyclonal antiserum to a microtubule-associated protein (MAP) from mouse neuroblastoma cells (MAP 4) was used to examine the distribution of this protein in mouse tissues. Immunoblots of neuroblastoma cell microtubule protein preparations demonstrated that the antiserum reacted with a triplet of proteins at 215,000-240,000 mol wt. Antibodies affinity purified from any of the bands showed cross-reaction with the other bands, indicating these polypeptides were all immunologically related. Antibodies specific to MAP 4 decorated microtubules in cultured murine cells fixed with glutaraldehyde, and diffuse staining was seen following treatment of cells with nocodazole. The antiserum reacted with MAP 4 in extracts of brain, heart, liver, and lung from adult mouse; the triplet in brain was more closely spaced than in the other tissues or neuroblastoma cells. In kidney, spleen, and stomach, only a single band (band 4) was labeled; this band was immunologically related to the triplet and was also present in all tissues positive for the triplet. Skeletal muscle, sperm, and peripheral blood contained no reactive polypeptides. After taxol-induced polymerization, the MAP 4 triplet was preferentially associated with the microtubule pellet whereas band 4 remained in the supernatant. These data indicate that there is tissue specificity in the distribution of MAP 4, and that some tissues contain a polypeptide related to MAP 4 (band 4) that does not bind to microtubules in vitro.
The existence of proteins that co-assembled with tubulin (8, 23, 32) and that decorated the surface of microtubules (13, 20, 22, 33, 38, 43) was initially derived from studies with brain tissue. However, most work on the distribution of these microtubule-associated proteins (MAP) ~ has been carried out with cultured cells. Studies in which polyclonal antisera raised against high molecular weight MAP (MAP 1 and MAP 2) (9, 10, 12, (29) (30) (31) or low molecular weight MAP (tau) (9) (10) (11) were found to label microtubule networks in non-neuronal cells suggested that proteins homologous to the brain MAP were widely distributed among cell types. More recently, monoclonal antibodies to a subspecies of brain MAP 1, MAP 1A, have been shown to react with various continuous cell lines (4) , whereas monoclonal antibodies to MAP 2 have been found to have a more restricted distribution (18, 19) . While all of these studies indicate that MAP similar to those found in brain exist in continuously growing cultures, little is yet known about the occurrence of any of these proteins in nonneuronal tissues.
MAP distinct from those of brain were identified when ~ Abbreviations used in this paper." MAP, microtubule-associated proteins; PMSF, phenylmethylsulfonyl fluoride; TAME, Na-p-tosyl-L-arginine methyl ester.
clonal cell lines were used as sources of microtubules. For example, in vitro assembly of microtubules demonstrated major MAP of 125,000 and 210,000 mol wt in HeLa cells (5, 39, 40) and 215 mol wt in mouse neuroblastoma cells (26) . By using selective solubilization, major MAP species of -200,000-220,000, 80,000, and 69,000 mol wt were found in a variety of cell types (14) . Although the 69,000-mol-wt MAP from cells showed peptides in common with tau proteins from brain (14) , the high molecular weight species differed in molecular weight from brain MAP 1 or 2. In addition, the proteins in the 200,000-220,000-mol-wt range showed differences in molecular weight between rodent and human cell lines.
Although the studies cited above have shown that a number of MAP can be identified in cultured cells, the occurrence of any these proteins in primary tissues other than brain has not yet been investigated. Our previous work indicated that the MAP we had identified in mouse neuroblastoma cells was present in very low amounts in cells (27) , and we therefore raised antibodies to use as probes for the localization of this protein. As described subsequently, this MAP, originally identified as having a molecular weight of 215,000, is actually a complex of related polypeptides ranging in molecular weight between 215,000 and 240,000, this complex will be referred to as MAP 4. This paper describes the complexity of MAP 4 in a variety of mouse tissues and demonstrates that this MAP is restricted to a subset of these tissues.
MATERIALS AND METHODS

Antibody Preparations
A polyclonal antiserum was produced in a New Zealand White rabbit using microtubule protein fractions (I-LP; 1 mg total for all injections) obtained from differentiated neuroblastoma cells by four cycles of D20-induced assembly (27) . Samples were resuspended in PBS and sonicated with an equal volume of complete Freund's adjuvant and the rabbit was injected subcutaneously with a total of 1.4 ml of immunogen, 0.7 ml in each of two sites on the back. 1 wk later, an additional 1.4 ml of immunogen was injected. The rabbit was bled 2 wk after the second injection, and then every 3--4 d for 12 wk. For some experiments, antibodies to the proteins of interest (see Results) were affinity purified from diazotized paper blots (24), and were used to reprobe blots or for immunostaining. Absorption of the whole antiserum with purified tubulin had no effect on the labeling patterns on blots or cells. Tubulin antisera were prepared as described previously (37) .
Immunoblots
Protein samples were resolved by SDS PAGE (4--6, 7, or 8% acrylamide gels) (21) and then electrophoretically transferred to diazotized paper blots paper (34) or nitrocellulose (modified from Towbin et at. 135] by inclusion of 0.1% SDS [ 15] in the blotting buffer). Under the conditions used, proteins of all molecular weights transferred efficiently to the blots. Blots were incubated with antibodies for 10-18 h at room temperature, and antibody binding was detected either with iodinated protein A (2 x 105 or 106 cpm/ml) and autoradiography, or with goat anti-rabbit serum coupled to peroxidase and reacted with 4-chloro-l-naphthol or O-dianisidine. Gels were stained for protein with Coomassie Blue, and blots were stained with amido black.
Immunomicroscopy
For indirect immunofluorescence, cells that had been plated on coverslips were fixed for 10 min at room temperature with 1.0% glutaraldehyde in 0.1 M PIPES, pH 6.9. Cells were rinsed in 0.I M PIPES, and extracted with 0.5-1% Triton-X 100 in 0.1 M PIPES for 30 min (three changes). Covet'slips were rinsed in PBS, reduced with 1 mg/ml NaBtL in three parts 0.1 M PIPES/I part 99% EtOH for 15 min (five changes), rinsed, and then incubated with 1% BSA in PBS or Tris-buffered saline, pH 7.6, for 30 min at room temperature. Coverslips were then split in two, and each half was incubated with blot-purified antibodies to MAP 4 or tubulin antiserum for 30 min at 37"C. After rinsing, coverslips were incubated with fluorochrome-conjugated goat anti-rabbit serum (Miles Laboratories Inc., Elkart, IN), rinsed, and mounted in Gelvatol. Samples were photographed using a Zeiss universal microscope equipped with epifluorescence optics.
Molecular Weight Determination
7 or 4-6% gradient gels were prepared which contained microtubule preparations from neuroblastoma cells or mouse tissues. The migration of the proteins of interest were compared with those of MAP 2 (270,000 mol wt), alpha-spectrin (245,000 mol wt), beta-spectrin (220,000 tool wt), myosin heavy chain (205,000 tool wt), and B-galactosidase (116,000 tool wt), and the molecular weights were estimated from a semi-log standard plot of denatured molecular weights relative to migrated distance.
RESULTS
Immunoblotting was used initially to characterize the antiserum raised to four-cycled microtubule protein preparations (27) from mouse neuroblastoma cells. As shown in the Coomassie Blue-stained gel in Fig. 1 A, a microtubule pellet (lane 1) prepared by taxol-ariven assembly from neuroblastoma cell extracts contained a number of protein bands in addition to tubulin. Immunoblot analysis ( Fig. 1 B , lane 1) of this sample demonstrated that the MAP 4 antiserum reacted with a triplet of bands; similar results have been obtained with immunoblots of cycled microtubule protein preparations from neuroblastoma cells (26) . The presence of all three polypeptides with the microtubule pellet indicated that all of these proteins were MAP. The mobility of the reactive species was between 215,000 and 240,000 mol wt; this is the same range of molecular weight as the dominant neuroblastoma MAP. This MAP, originally designated as 215,000 tool wt (27) , has been shown here to be similar in mobility to alpha-spectrin (240,000 mol wt, see Fig. 3 for comparison), and will be called MAP 4. No reaction was observed in the region of tubulin,
Sample Preparations
MOUSE TISSUES: Mice were killed by cervical dislocation, and organs were removed and placed on ice. Organs were immediately homogenized in 0.1 M PIPES, pH 6.9, 0.1 mM MgCI2, 1.0 mM EGTA, 2.5 mM GTP, 1.0 mM phenylmethylsulfonyl fluoride (PMSF) (PMEG) (ratio of 1.0 g wet wt/l.5 ml buffer). For portions of this study, 10 mM Na-p-tosyl-L-arginine methyl ester (TAME) and 0.1 mg/ml trypsin inhibitor were also included in the PMEG. We prepared extracts by centrifugation for 40 min at 38,000 g and by centrifuging the resultant supernatants for 90 min at 40,000 rpm (Beckman type 65 rotor, Beckman Instruments, Inc., Palo ARo, CA). Mouse erythrocytes were washed three times in cold PBS with 1 mM PMSF. Ghosts were prepared by washing the erythrocytes three times with Buffer H (17) . The erythrocyte membranes were collected with 10-rain spins at 38,000 g between each wash.
M I C R O T U B U L E AND MAP P R E P A R A T I O N S ; Extracts were prepared
and microtubules were polymerized from neuroblastoma cells using either 020- (27) or taxol-(36) driven assembly. Microtubules from mouse tissues were obtained using the taxol-procedure of Vallce (36) , except that 20 t~M taxol was used for brain extracts, and 40 gM taxol for all other organs or tissues. After sedimentation of the microtubules, the supernatant (designated HSr) was removed, and the pellet (HPT) was washed with PMEG containing 20 pM taxol and recentrifuged. Brain microtubules were also prepared by cycles of assembly (28) . We prepared thermostable MAP (16) by boiling microtubule fractions resuspeuded in 0. l M PIPES, 0.2 mM MgC12, 2 mM EGTA, 2.5 mM GTP, 2.2 mM dithiothreitol, l mM PMSF, 0.75 M NaCl, pH 6.9, for 5 rain, and centrifuging the boiled sample at 14,000 g for 15 min. indicating lack of detectable antibodies to this highly conserved protein.
The relationship of the triplet of polypeptides detected by immunoblotting was analyzed in neuroblastoma extracts. 4-6% gradient gels were used to achieve greater separation of the reactive species (e.g., Fig. 3 C) and antibodies specific to each of these bands were prepared by affinity purification of the antibodies from individual bands on blots (24). Antibodies eluted from any of the bands reacted with all other bands in this region and indicated that these were immunologically related. These bands were also present in neuroblastoma extracts prepared under conditions where proteolysis would have been favored (no protease inhibitors, incubation of homogenates for 1 or 2 h at 0* or 37"C), as well as under conditions that minimized in vitro proteolysis (protease inhibitors, immediate boiling of cells in SDS sample buffer). These data (also see Fig. 4 ) suggested that all of the polypeptides recognized by the MAP 4 serum were present in vivo.
In addition to sharing antigenic determinants and the ability to co-assemble with microtubules, the three polypeptides of the MAP 4 complex were also similar in remaining soluble after boiling. An aliquot of the microtubule preparation shown in Fig. 1A was boiled, and the resultant supematant and pellet were analyzed by immunoblotting. As shown in Fig. 1 B, all three of the polypeptides present in the microtubule fraction (lane 1) were recovered in the supernatant after boiling (lane 3). Thus, like MAP 2 (16), HeLa 210,000-molwt MAP (41) , and tau (8), the proteins of the MAP 4 complex appear to be thermostable. To remain consistent with the nomenclature recently given to MAP 1 and MAP 2 subspecies (3), we designate the thermostable species reacting with the MAP 4 antisera MAP 4A, MAP 4B, and MAP 4C in order of increasing mobility on SDS gels.
Using antibodies affinity purified from the MAP 4 triplet, immunofluorescent staining was used to assess whether this protein was also associated with microtubules in situ. As shown in Fig. 2 A, MAP 4-specific antibodies showed a pattern in 3T3 cells similar to that seen with the tubulin antiserum ( Fig. 2 B) . Following treatments that disrupted microtubules, diffuse intracellular staining was observed with either the purified antibodies to MAP 4 ( (2), MAP 4 appears to diffuse throughout the cytoplasm.
While the preceding data demonstrated that the MAP 4 antibodies reacted with MAP in cultured murine cells, a primary goal was to establish whether this MAP was present in mouse tissues. Therefore, we prepared immunoblots of extracts from various mouse tissues and probed them with the antiserum. Fig. 3 shows that the antiserum reacts with polypeptides in heart, liver, and lung similar in molecular weight to those in neuroblastoma extracts. Brain also shows a similar pattern, although the triplet is more closely spaced and MAP 4C is not as prominent as in neuroblastoma or other tissues. No triplet is present in kidney, spleen, or stomach. However, these tissues, as well as brain, heart, liver, and lung, contain a lower molecular weight polypeptide (band 4) that reacts with the antiserum (see below). Several preparations contained neither the triplet nor band 4; these included skeletal muscle from thigh, mouse erythrocyte membranes ( Fig. 3) , whole peripheral blood, and isolated sperm (data not shown). Thus, the complexity and extent of cross-reaction of polypeptides with the MAP 4 antiserum varied depending on tissue origin.
Organ homogenates prepared under various conditions were examined to determine whether the diversity in the patterns seen by immunoblotting might be the result of in vitro proteolysis. Samples were prepared from brain homogenized in boiling sample buffer, or from brain homogenates incubated at 0* or 37"C in the presence or absence of PMSF, TAME, and trypsin inhibitor. As shown in Fig. 4 , immunoblots demonstrate that the polypeptide patterns are identical under all conditions tested. Similar results were obtained in examining other tissue samples; MAP 4B, MAP 4C, and band 4 were present in tissues homogenized immediately in boiling sample buffer, and showed no change on prolonged incubation, suggesting that these bands exist in vivo.
In addition to the MAP 4 triplet, the whole antiserum labeled two other bands in brain extract, one additional band in neuroblastoma extract, and one doublet in heart extract (see Fig. 3 ). The two bands labeled in brain extract comigrated with MAP 1 and MAP 2 from mouse brain microtubules obtained by taxol-driven assembly (see Fig. 7) . The cross-reactive species in neuroblastoma extract co-migrated with a protein, originally identified as having a molecular weight of 310,000, that associates with microtubules through three cycles of assembly (27) . Although present in blots of extracts, this protein was not consistently detected in immunoblots of microtubule preparations from neuroblastoma cells. Antibodies were affinity purified from the region of 1312 THE JOURNAL OF CELL BIOLOGY • VOLUME 99, 1984 FIGURE 5 Immunoblots probed with antibodies affinity purified from MAP 4 region and MAP 1 region. Neuroblastoma, brain, and heart extract were electrophoresed on a 7% gel, blotted, and then incubated with (A) whole MAP 4 antiserum, (B) antibodies affinity purified from the MAP 4 band, (C) antibodies affinity purified from the MAP 1 region. Nb, neuroblastoma; Br, brain; He, heart. Antibodies eluted from MAP 4 (all three bands) reacted only with MAP 4 in each extract (B). Affinity-purified MAP 1 antibodies reacted with MAP 1 in brain and with a higher molecular weight protein (>350,000 mol wt of MAP 1) in neuroblastoma extract (C). The low molecular weight bands labeled with whole serum in neuroblastoma or brain extract are present in the preimmune serum, and are not related to the immunogen. Two dots, MAP 1; arrowhead, MAP 4; dash, band 4. MAP 1 and MAP 4 and used to investigate the relationship of these antigenic species on blots of neuroblastoma, heart, and brain extract. Fig. 5 shows that the antibodies eluted from the MAP 4 complex (seen in this autoradiogram as a fused band) react exclusively with the triplet and band 4 in each extract (Fig. 5 B) . Antibodies eluted from MAP 1 react with MAP 1 in brain and the high molecular weight polypeptide in neuroblastoma extract (Fig. 5 C) . These data indicate these proteins are immunologically related, although the neuroblastoma protein has a higher molecular weight than MAP 1. Sufficient antibodies have not yet been obtained from the area of MAP 2 to assess the relatedness of this protein to other proteins in these extracts. However, as indicated by lack of reaction of affinity-purified antibodies from MAP 1 or MAP 4 with each other or with MAP 2, the three MAP detected in brain extracts all appear to be distinct entities. Antibodies eluted from a control area of diazotized paper blots showed no labeling.
Similar experiments were carded out to determine the relation of band 4 to the MAP 4 triplet. Antibodies from the triplet or band 4 were affinity purified from blots of organ extracts, and were used to probe blots of kidney and lung extracts. Fig. 6 shows that antibodies eluted from the MAP 4 complex will label the triplet in lung as well as band 4 in kidney. Antibodies eluted from band 4 will label only band 4 in blots of kidney extracts but will label the MAP 4 complex and band 4 in organs that possess the MAP 4 triplet. These data indicate that MAP 4A, 4B, and 4C and band 4 all share antigenic determinants.
MAP 4A, B, and C had been identified as MAP from the in vitro polymerization studies using neuroblastoma cell extracts, but we also wished to examine whether these MAP and band 4 co-polymerized with microtubules from tissue extracts. As shown in Fig. 7 , microtubule pellets (HPT) enriched in tubulin could be obtained from tissue extracts using the assembly promoting drug, taxol; gels of the corresponding supematants (HST) were essentially identical in composition to the extracts shown in Fig. 3 , except for the diminution of tubulin. As shown in the blots (Fig. 7, A and B) , microtubule pellets from brain, heart, liver, and lung extracts contained MAP 4A, and varying amounts of 4B and C, whereas only small amounts of any of these bands remained in the HST fraction (compare immunoblots of HPT and HSt of brain, heart, liver, and lung in Fig. 7) . In contrast, microtubules prepared from kidney and spleen showed no reaction with the MAP 4 antiserum. Band 4, previously identified in extracts of these tissues, was present in the HST fraction. These data suggested that MAP 4A, B, and C can polymerize with microtubules, and therefore are MAP, whereas band 4, although immunologically related to the triplet, does not have the ability to bind to taxol-stabilized microtubules.
DISCUSSION
Immunoblotting and affinity purification of antibodies have shown that MAP 4 is a complex of related polypeptides; the complex exists both in mouse cell lines (25) and as shown here, in a number of mouse tissues. All three bands of the complex co-assemble with microtubules, and all are thermostable. The 210,000-mol-wt MAP of HeLa is also thermostable (41) , and it has been reported this MAP is also a triplet of polypeptides (6) , although the antiserum raised to this preparation reacted with only a single band on gels. These properties of thermostability, complexity, and similarity in molecular weight indicate that MAP 4 and the 210,000-molwt HeLa MAP may be species-specific homologues. Complexity in both brain MAP 1 (3) and MAP 2 (1, 3) has also recently been described. Low percentage gels resolved each of these brain MAP into discrete species. MAP 2 split into two bands, both of which were thermostable. MAP 1 split into three bands, of which two (MAP 1A and IB) were more sensitive to proteases than MAP 1C. Monoclonal antibodies raised to MAP 1 reacted only with MAP IA, suggesting that although the MAP 1 subspecies are functionally related (associate with microtubules in vitro), they are structurally different polypeptides. As discussed subsequently, the subtle differences in the polypeptides of the MAP complexes may be important in understanding the cell or tissue-specific functions of these molecules.
The distribution of the MAP 4 complex shows variation among mouse tissues. Certain tissues (brain, heart, liver, lung) contain the MAP 4 triplet, and this complex co-assembles with microtubules derived from extracts of these tissues. In contrast, other tissues (kidney and spleen) contain only band 4, a polypeptide that does not bind to microtubules in vitro, but that is antigenically related to MAP 4. Some tissues (skeletal muscle), and microtubules derived from them, show no reaction with the antiserum. Immunoblotting analyses indicated that the proteins reacting with the MAP 4 antiserum, especially MAP 4B, C, and band 4, are present in very low but reproducible amounts in certain tissues. As is shown in the preparations of microtubules obtained from brain, MAP 4 is a very minor component compared with the dominant brain MAP, MAP 1, and MAP 2 (Fig. 7) . Immunoblotting has shown that the spacing of MAP 4B, C, and band 4 in brain differs slightly from that in other mouse tissues or neuroblastoma cells. These data suggest that the MAP 4 complex in brain may be unlike that in other tissues, although the MAP 4 polypeptides in all tissues we have examined share the properties of immunologic cross-reaction and thermostability.
Our findings on the heterogeneity of the MAP 4 patterns in tissues contrast with the results on the distribution of the 210,000-mol-wt HeLa MAP. Antisera raised against the 210,000-mol-wt HeLa MAP reacted with a single band in extracts from human brain, or lysates from continuous human or primate cell lines originally derived from liver, kidney, muscle, spleen, bladder, connective tissue, and leukocytes (7) . This difference could reflect particular epitope speciflcities of the two antisera used. Alternatively, the MAP distribution in cultured cells may not mimic the complexity in distribution seen in whole tissues. Differences have also been found in the 1314 THE JOURNAL OF CELL BIOLOGY • VOLUME 99, 1984 distribution of brain MAP 1 and 2 in cultured cells as compared with tissues. For example, although initial studies demonstrated that antibodies raised against high molecular weight MAP labeled microtubule networks in cultured cells (12, (29) (30) (31) , the organization of the two major brain MAP in brain tissue has recently been demonstrated to be distinguishable. MAP 1 is widespread in both grey and white matter (3), whereas MAP 2 is restricted to neuronal cell bodies and dendrites (2, 3) . All of these studies suggest that examining the distribution of MAP in adult tissues may be important in ultimately understanding how various MAP function in situ. For example, our recent immunocytologic analyses demonstrate that MAP 4 is very specifically localized to a subset of cells within each tissue type (Parysek, L. M., J. B. Wolosewick, and J. B. Olmsted, J. Cell Biol., in press).
In addition to reacting with the MAP 4 protein in brain, the whole antiserum used in some of these studies labeled MAP 1 and, to a much lesser extent, MAP 2 in brain extracts. Affinity-purified antibodies to MAP 1 and MAP 4 did not cross-react with the nonhomologous antigens, nor with MAP 2. These data indicate that the three MAP in brain are immunologically distinct. Although proteins analogous to brain MAP 1 or MAP 2 were not detected in the original microtubule protein preparations from neuroblastoma cells used for immunogen, the presence of antibodies reacting with these species indicates that antigenically related proteins must be present in these cells. Wiche et al. (42) and Bloom et al. (4) have shown that a high molecular weight protein in neuroblastoma cells cross-reacts with antisera raised to MAP 1 from brain. However, our data demonstrated that the high molecular weight protein in neuroblastoma extracts reacting with affinity-purified antibodies to MAP 1 has a lower electrophoretic mobility than MAP 1 (Fig. 7) . Bloom et al. (4) have also recently shown that monoclonal antibodies to MAP 1A from brain react with cultured cell lines derived from a number of species and tissue origins; in some of these cells, this monoclonal antibody appears to react with closely spaced doublets, or with proteins of higher molecular weight than MAP 1A (e.g., Chinese hamster ovary cell line). We found, however, no reaction in the MAP 1 region of blots of tissues other than brain. It remains to be determined whether the MAP 1 species recognized by our antiserum may be different than that reacting with MAP 1A, or whether MAP 1A is restricted in tissues as compared with cell lines. Our data indicate that of the three MAP species in mouse brain recognized by the whole antiserum, only MAP 4 is prevalent in a number of mouse tissues. More detailed analyses of the localization and expression of each of the components of the MAP 4 complex, as well as other MAP, should indicate if discrete structure-function correlations for these proteins in tissues can be made.
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